2Huber HL, Koessler KK. The pathololgy of bronchial asthma. Arch Intern Med, 1922, 30:689-760.
3Bramley AM ,Thomson RJ, Roberts CR, et al. Excessive bronchocon- struction in asthma is due to decreased airway elastance. Eur Respir J,1994,7:337 -541.
4Broekelmann TJ, Limper AH, Cobly TV, et al. Transforming growth factorβ1 is present at sites of extracellular matrixgene expression in human pulmonary fibrosis. Proa Natl Acad Sci USA, 1991,88 (15) : 6642 - 6646.
6James AL, Hogg JC, Dunn LA, et al. The use of the interal perimeter to compare airway size and to calculate smooth mus-cle shortening. Am Rev Respir Dis, 1998,138 : 136 - 139.
8Bousquet J, Vignola AM, Chanez P, et al. airway remodeling in asthma:no doubt,no more?. Int Arch Allergy Immunol, 1995,107:211 -214.
9Backman KS, Greenberger PA, Patterson R, et al. Airway obstruction in patients with long term asthma consistent with" irreversible asthma". Chest,1997,112:1 234 - 1 240.
10Morishima Y, Nomura A, Uchida Y, et al. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol,2001,24 : 1 - 11.
8Zhang DW, Zhao YX, Wei D, Li YL, Zhang Y, Wu J, Xu J, Chen C, Tang H, Zhang W, Gong L, Han Y, Chen ZN, Bian H. HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis. J Hepatol 2012; 57:1283-1291 [PMID: 22878468 DOI: 10.1016/ j.jhep.2012.07.042].
